Iridex reiterated its financial outlook for 2023, expecting Cyclo G6 probe sales of 65,000 to 67,000 representing approximately 9% to 12% growth over 2022 and to expand the Cyclo G6 systems installed base by 225 to 250 systems. Total revenue for the full year is expected to be $57 million to $59 million. 2023 total revenue guidance represents growth of approximately 3% to 6% after adjusting for an approximate $1.5 million reduction of Other Revenue royalty income resulting from the expiration of licensed patents.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.868 USD | +0.64% | -2.44% | +2.07% |
Mar. 26 | Transcript : IRIDEX Corporation, Q4 2023 Earnings Call, Mar 26, 2024 | |
Mar. 26 | Earnings Flash (IRIX) IRIDEX CORPORATION Reports Q4 Revenue $12.5M, vs. Street Est of $14.9M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.07% | 46.32M | |
+8.13% | 217B | |
+6.69% | 183B | |
+10.38% | 131B | |
+25.24% | 106B | |
-0.95% | 62.16B | |
+11.04% | 51.02B | |
+4.81% | 50.89B | |
-0.42% | 40.16B | |
+0.47% | 34.79B |
- Stock Market
- Equities
- IRIX Stock
- News IRIDEX Corporation
- IRIDEX Corporation Reiterates Financial Guidance for 2023